z-logo
open-access-imgOpen Access
Pembrolizumab Improves PFS in Metastatic Urothelial Cancer
Author(s) -
Brandon May
Publication year - 2020
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000681532.01963.13
Subject(s) - pembrolizumab , medicine , blockade , metastatic urothelial carcinoma , oncology , context (archaeology) , cancer , chemotherapy , urothelial cancer , immune checkpoint , immunotherapy , bladder cancer , urothelial carcinoma , paleontology , receptor , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here